Smith+Nephew Closes Acquisition of Integrity Orthopaedics

Smith+Nephew completed the acquisition of Integrity Orthopaedics, expanding its sports medicine shoulder repair business with a comprehensive suite of technologies available for rotator cuff repair (RCR).

Integrity Orthopaedics is a U.S.‑based, early‑stage commercial developer of Tendon Seam, a biomechanical RCR system designed to significantly reduce re‑tear rates and improve patient outcomes versus the present standard of care.

Tendon Seam is currently available in the U.S. Similar to post-acquisition efforts with the REGENETEN Bioinductive Implant, Smith+Nephew plans to accelerate adoption leveraging its commercial channels in the U.S. while building a base of evidence to support global adoption.

Tendon Seam allows for a novel repair stitch configuration with multiple points of fixation. Its patented microanchors, continuous suture, individually locked stitches, and integrated implantation instrument are designed to deliver stronger repairs, accelerated patient recovery, lower re-tear rates, and a simplified surgical technique. Early clinical experience indicates low re-tear rates, reduced sling times, and shorter procedures compared with standard methods. The system received 510(k) clearance in 2023 and is indicated for reattachment of soft tissue to bone, including tendons, ligaments, and joint capsules.

Tendon Seam complements the REGENETEN Bioinductive Implant, giving Smith+Nephew a differentiated RCR portfolio.

“Surgeons and patients deserve a rotator cuff repair solution that delivers results they can count on,” said Christie Van Geffen, Senior Vice President of Sports Medicine Marketing for Smith+Nephew. “They now have that with Tendon Seam™ and REGENETEN – and we look forward to helping more tendon repairs heal, improving patient outcomes, and setting a new standard of care.”

Source: Smith+Nephew